Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12271283.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A patient with widespread in situ squamous cell carcinoma of the glans penis was successfully managed with topical application of 5% imiquimod cream. Therapy with topical immune response modifiers may prove beneficial in cases of superficial cutaneous carcinoma and may, if future studies confirm our findings, play a role in settings in which more destructive techniques may result in cosmetic defects or functional impairment. The use of imiquimod for intraepithelial squamous cell carcinoma of the anogenital area seems particularly logical because of the strong correlation between this neoplasm and infection with human papillomavirus.
Medical subject headings
- Adjuvants, Immunologic
- Aminoquinolines
- Carcinoma in Situ
- Carcinoma, Squamous Cell
- Interferon Inducers
- Penile Neoplasms